Literature DB >> 17958985

Anti-tuberculosis drug resistance among new and previously treated pulmonary tuberculosis patients in Cotonou, Benin.

D Affolabi1, O A B G Adjagba, B Tanimomo-Kledjo, M Gninafon, S Y Anagonou, F Portaels.   

Abstract

OBJECTIVES: To assess the current anti-tuberculosis drug resistance situation in Cotonou, at the largest anti-tuberculosis centre of Benin.
METHODS: A total of 470 isolates of Mycobacterium tuberculosis complex from pulmonary tuberculosis (TB) patients were analysed: 244 from new cases and 226 from previously treated cases. Drug susceptibility testing of isolates against first-line drugs was performed using the proportion method.
RESULTS: Primary multidrug resistance (MDR) depends on the patients' origin: MDR in new cases is relatively high (1.6%) when all patients are considered, but low (0.5%) and comparable to 1994 national survey results when only patients residing in Benin are considered. MDR in previously treated patients (11.1%) remains comparable to the study performed in Benin in 1994. No relation was found between human immunodeficiency virus co-infection and anti-tuberculosis drug resistance.
CONCLUSION: This study shows the great importance of correct patient identification in epidemiological surveys, where results may vary according to the population(s) studied.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17958985

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  14 in total

1.  MDR-TB treatment needs in patients previously treated for TB in Cotonou, Benin.

Authors:  S Ade; A Trébucq; A D Harries; D Affolabi; G Ade; G Agodokpessi; P Wachinou; S Anagonou; M Gninafon
Journal:  Public Health Action       Date:  2013-06-21

Review 2.  Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis.

Authors:  Deus Lukoye; Willy Ssengooba; Kenneth Musisi; George W Kasule; Frank G J Cobelens; Moses Joloba; Gabriela B Gomez
Journal:  BMC Public Health       Date:  2015-03-25       Impact factor: 3.295

3.  The Mycobacterium tuberculosis Uganda II family and resistance to first-line anti-tuberculosis drugs in Uganda.

Authors:  Nicholas Ezati; Deus Lukoye; Eddie M Wampande; Kenneth Musisi; George W Kasule; Frank G J Cobelens; David P Kateete; Moses L Joloba
Journal:  BMC Infect Dis       Date:  2014-12-19       Impact factor: 3.090

4.  Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia.

Authors:  Shallo Daba Hamusse; Dejene Teshome; Mohammed Suaudi Hussen; Meaza Demissie; Bernt Lindtjørn
Journal:  BMC Public Health       Date:  2016-07-18       Impact factor: 3.295

5.  Low Occurrence of Tuberculosis Drug Resistance among Pulmonary Tuberculosis Patients from an Urban Setting, with a Long-Running DOTS Program in Zambia.

Authors:  Chanda Mulenga; Allan Chonde; Innocent C Bwalya; Nathan Kapata; Mathilda Kakungu-Simpungwe; Sven Docx; Krista Fissette; Isdore Chola Shamputa; Françoise Portaels; Leen Rigouts
Journal:  Tuberc Res Treat       Date:  2010-06-30

6.  A meta-analysis of drug resistant tuberculosis in Sub-Saharan Africa: how strongly associated with previous treatment and HIV co-infection?

Authors:  Asres Berhan; Yifru Berhan; Desalegn Yizengaw
Journal:  Ethiop J Health Sci       Date:  2013-11

7.  Prevalence and Drug Resistance Patterns of Mycobacterium tuberculosis among New Smear Positive Pulmonary Tuberculosis Patients in Eastern Ethiopia.

Authors:  Berhanu Seyoum; Meaza Demissie; Alemayehu Worku; Shiferaw Bekele; Abraham Aseffa
Journal:  Tuberc Res Treat       Date:  2014-04-16

8.  Drug resistance of Mycobacterium tuberculosis isolates from tuberculosis lymphadenitis patients in Ethiopia.

Authors:  Fantahun Biadglegne; Belay Tessema; Ulrich Sack; Arne C Rodloff
Journal:  Indian J Med Res       Date:  2014-07       Impact factor: 2.375

9.  Characteristics and Treatment Outcomes of Retreatment Tuberculosis Patients in Benin.

Authors:  Serge Ade; Omer Adjibodé; Prudence Wachinou; Narcisse Toundoh; Bérénice Awanou; Gildas Agodokpessi; Dissou Affolabi; Gabriel Adè; Anthony D Harries; Séverin Anagonou
Journal:  Tuberc Res Treat       Date:  2016-03-24

10.  Drug susceptibility profiles of pulmonary Mycobacterium tuberculosis isolates from patients in informal urban settlements in Nairobi, Kenya.

Authors:  Glennah Kerubo; Evans Amukoye; Stefan Niemann; Samuel Kariuki
Journal:  BMC Infect Dis       Date:  2016-10-19       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.